TY  - GEN
AU  - Kimberlin,David W
AU  - Whitley,Richard J
AU  - Wan,Wen
AU  - Powell,Dwight A
AU  - Storch,Gregory
AU  - Ahmed,Amina
AU  - Palmer,April
AU  - Sánchez,Pablo J
AU  - Jacobs,Richard F
AU  - Bradley,John S
AU  - Robinson,Joan L
AU  - Shelton,Mark
AU  - Dennehy,Penelope H
AU  - Leach,Charles
AU  - Rathore,Mobeen
AU  - Abughali,Nazha
AU  - Wright,Peter
AU  - Frenkel,Lisa M
AU  - Brady,Rebecca C
AU  - Van Dyke,Russell
AU  - Weiner,Leonard B
AU  - Guzman-Cottrill,Judith
AU  - McCarthy,Carol A
AU  - Griffin,Jill
AU  - Jester,Penelope
AU  - Parker,Misty
AU  - Lakeman,Fred D
AU  - Kuo,Huichien
AU  - Lee,Choo Hyung
AU  - Cloud,Gretchen A
TI  - Oral acyclovir suppression and neurodevelopment after neonatal herpes
SN  - 1533-4406
PY  - 2011///1024
KW  - Acyclovir
KW  - adverse effects
KW  - Antiviral Agents
KW  - Central Nervous System Diseases
KW  - drug therapy
KW  - Child Development
KW  - drug effects
KW  - Double-Blind Method
KW  - Female
KW  - Herpes Simplex
KW  - Humans
KW  - Infant, Newborn
KW  - Kaplan-Meier Estimate
KW  - Male
KW  - Pregnancy Complications, Infectious
KW  - Secondary Prevention
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.1056/NEJMoa1003509
ER  -